Fennec Pharmaceuticals (FENC) EBIT Growth (3y) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 32.96% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -29.67% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -50.81% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 13.47% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 16.35% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -12.10% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 55.96% |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn | 33.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 33.15% |
| Sep 30, 2025 | 71.18% |
| Jun 30, 2025 | 18.30% |
| Mar 31, 2025 | 38.92% |
| Dec 31, 2024 | 39.45% |
| Sep 30, 2024 | -7.62% |
| Jun 30, 2024 | -8.73% |
| Mar 31, 2024 | 68.59% |
| Dec 31, 2023 | 18.40% |
| Sep 30, 2023 | 44.22% |
| Jun 30, 2023 | 1.25% |
| Mar 31, 2023 | -11.18% |
| Dec 31, 2022 | -18.87% |
| Sep 30, 2022 | -61.85% |
| Jun 30, 2022 | -1.34% |
| Mar 31, 2022 | -9.78% |
| Dec 31, 2021 | -10.65% |
| Sep 30, 2021 | -13.58% |
| Jun 30, 2021 | -13.73% |
| Mar 31, 2021 | -40.08% |
| Dec 31, 2020 | -9.98% |
| Sep 30, 2020 | -38.91% |
| Jun 30, 2020 | -48.52% |
| Mar 31, 2020 | -70.70% |
| Dec 31, 2019 | -47.17% |
| Sep 30, 2019 | -48.93% |
| Jun 30, 2019 | -89.52% |
| Mar 31, 2019 | -80.73% |
| Dec 31, 2018 | -77.95% |
| Sep 30, 2018 | -103.49% |
| Jun 30, 2018 | -69.32% |
| Mar 31, 2018 | -58.24% |
| Dec 31, 2017 | -47.05% |
| Sep 30, 2017 | -52.28% |
| Jun 30, 2017 | -16.72% |
| Mar 31, 2017 | -12.81% |
| Dec 31, 2016 | -40.18% |
| Sep 30, 2016 | -122.79% |
| Jun 30, 2016 | 8.63% |
| Mar 31, 2016 | 5.44% |
| Dec 31, 2015 | 21.13% |
| Sep 30, 2015 | 18.74% |
| Jun 30, 2015 | 23.99% |
| Mar 31, 2015 | 9.80% |
| Dec 31, 2014 | 4.28% |
| Sep 30, 2014 | 13.12% |
| Jun 30, 2014 | -17.59% |
| Mar 31, 2014 | 19.28% |
| Dec 31, 2013 | 20.11% |
| Sep 30, 2013 | 61.83% |
| Jun 30, 2013 | 28.21% |